发明授权
- 专利标题： Imidazole derivatives as factor Xa inhibitors
- 专利标题（中）： 咪唑衍生物作为因子Xa抑制剂
-
申请号： US10728339申请日： 2003-12-04
-
公开(公告)号： US07358268B2公开(公告)日： 2008-04-15
- 发明人: Marc Nazare , Armin Bauer , Volkmar Wehner , David W. Will , Hans Matter , Michael Wagner , Herman Schreuder
- 申请人： Marc Nazare , Armin Bauer , Volkmar Wehner , David W. Will , Hans Matter , Michael Wagner , Herman Schreuder
- 申请人地址： DE Frankfurt am Main
- 专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人地址： DE Frankfurt am Main
- 代理商 Jiang Lin; Ronald G. Ort; Julie Anne Knight
- 优先权： EP02027120 20021204; EP03011307 20030519
- 主分类号： A61K31/42
- IPC分类号： A61K31/42 ; C07D261/04 ; C07D413/04
摘要：
This invention is directed to the compound of formula (I) which is useful for inhibiting the activity of Factor Xa. The present invention is also directed to compositions containing said compounds, processes for their preparation, their use, such as in inhibiting the formation of thrombin or for therapeutically or prophylactically treating a patient suffering from, or subject to, or associated with a disease state associated with a cardiovascular disorder.
公开/授权文献
- US20040171604A1 Imidazole derivatives as factor Xa inhibitors 公开/授权日：2004-09-02
信息查询
